Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France. The report date is March 12, 2026. The filing serves to transmit a press release dated March 12, 2026, to the U.S. Securities and Exchange Commission.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page and exhibit index referencing a press release, without including the financial data itself.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the formal submission of a press release (Exhibit 99.1) signed by CEO André Choulika.
Investor Verification Checklist
- Verify the content of the referenced Press Release (Exhibit 99.1) dated March 12, 2026, as the specific news or financial data is not included in this text.
- Confirm the company's current cash position and runway, as no liquidity figures are present in this filing.
- Review the full press release for any updates on clinical trials, partnerships, or strategic shifts.